10x基因组学

最新新闻

• 评级变动
  BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  J.P. Morgan Remains a Hold on 10x Genomics (TXG)
  TipRanks · 2026/8/11
• 评级变动
  Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $30 to $32
  \u5e02\u573a\u8d44\u8baf · 2026/4/21
• 评级变动
  Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Morgan Stanley Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $20.5
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Piper Sandler Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $50
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• RBC Capital Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $23 to $32
  \u5e02\u573a\u8d44\u8baf · 2026/5/9
• William Blair Maintains 10x Genomics(TXG.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $47
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $50 to $53
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/6/10
• 评级变动
  Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• Leerink Partners Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $90
  \u5e02\u573a\u8d44\u8baf · 2026/9/29

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。